Navigation Links
Growth in Biological Technology

Growth spurts

... ever direct observations in real-time of the growth of single nanocrystals in solution, which ... (NCEM), led a team of experts in nanocrystal growth and electron microscopy who combined their skills to observe the dynamic growth of colloidal platinum nanocrystals in solution ...

Microbix Sales Grow 22% For Nine Months

... exchange rates. The forecast is for continued growth in sales. "The 22% sales growth achieved in the nine months ending June 30, 2009 ... revenue in the following six months. We see the growth trend in product volume enjoyed in 2009 ...

ThermoGenesis Provides Update on Fiscal 2009 Results

... said the following factors are expected to drive growth and contribute to improved financial performance ... our quality will enable us to focus on our growth initiatives. We believe through the expansion of ... will be positioned to achieve meaningful growth in revenues during 2010," Engle added. "We ...

Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals' Lead Antibody

... cell responsible for driving tumor initiation, growth and recurrence. Research published in Cell Stem ... cell pathway impacts tumor cell proliferation, growth and recurrence." OMP-21M18 is a monoclonal ... that blocks DLL4 signaling to reduce tumor growth two ways: by reducing cancer stem cell frequency ...

Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009

... "We were pleased to observe continued sales growth in our Proprietary Medical Products business ... that may provide for more substantial revenue growth potential as compared to our overall product ... Products continued to demonstrate higher revenue growth as compared to our overall product portfolio, ...

The Breast Cancer Therapeutics Market in Australia

... including Epotheliones and Vascular Endothelial growth Factor Receptor (VEGFR) inhibitors." ... through our Pharmaceutical & Biotechnology growth Partnership Services programme. With continuous ... of the Complex Business Universe, the growth Partnership Services programme ensures that you ...

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

... $491 million +20% Product sales growth (excluding ADDERALL XR) at constant exchange ... with the same period in 2008. (2) Sales growth at constant exchange rates ("CER"), which is a ... XR, of $491 million, representing growth of 20% compared to the same quarter last year. ...

Ceregene Receives Additional Grant From Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients

... company focused on the delivery of nervous system growth (neurotrophic) factors for the treatment of ... CERE-110, an AAV2 based vector expressing nerve growth factor that is currently in a multi-center, ... include Alta Partners, MPM Capital, Investor growth Capital and Cell Genesys, Inc. (Nasdaq: CEGE ) ...

Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors

... supporting the use of GAM to deliver bone growth factors. Cardium believes that future DNA-based ... sustained cellular production of platelet-derived growth factor-B (PDGF-B) protein as a treatment for ... Celsius. PDGF-B protein is a well known bone growth mediator and is already used in several FDA ...

Caliper Life Sciences Reports Second Quarter 2009 Results

... Achieved 8% overall organic revenue growth compared to second quarter 2008 pro forma revenue: Optical Imaging: 17% growth (21% before currency impact) Research: 1% growth (5% before currency impact) CDAS: 14% ...

Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009

... to generate year-over-year quarterly revenue growth on a constant currency basis and to deliver ... step in one of our targeted areas of future growth by entering into a collaborative agreement with ... to $1.20, we're now projecting year-over-year growth in full year adjusted diluted EPS of ...

Sanofi-aventis Announces Second Quarter 2009 Results

... in the second quarter of 2009 Strong growth from Lantus(R) (up 26.0%), Lovenox(R) (up 13.3%) ... of Plavix(R) (up 9.6%) growth of 18.4% for the Vaccines business excluding H5N1 contracts(2) Net sales growth of 5.4% in the U.S., 4.6% in Europe and 20.1% in ...

NeoGenomics Reports Second Quarter 2009 Results

... During the second quarter, overall revenue growth was impacted by seasonality in our Florida-based ... second quarter, and particularly with the rate of growth of our business outside of the state of Florida," ... liquidity and flexibility in funding our growth initiatives." Robert Gasparini, the ...

Digitas Health Expands Adding Two Key Locations

... move is a strategic part of the agency's 2010 growth plan. Digitas Health has experienced increased annual revenue growth of approximately 50 percent in each of the last ... Digitas Health has enjoyed a long period of growth and accolades. The company's creative work was ...

PTC Therapeutics Initiates Phase 2 Clinical Trial of PTC299 in Patients with Neurofibromatosis Type 2

... block tumor-related vascular endothelial growth factor (VEGF). With its novel mechanism of ... VEGF expression necessary to maintain the growth and function of normal blood vessels. Patients ... production of the protein vascular endothelial growth factor (VEGF) in tumors. PTC discovered PTC299 ...

Histogen Hair Regrowth Clinical Trial Presented at ISHRS Annual Meeting

... of naturally secreted embryonic proteins, growth factors and contains the first naturally ... product, which contains Wnt proteins and other growth factors important to hair follicle maintenance ... compounds containing bioactive Wnt increase hair growth in humans." While additional clinical ...

PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of The Frost Group

... in the development of our long-acting human growth hormone candidate that has the potential to ... developing long-acting versions of human growth hormone, interferon beta and erythropoietin, ... well as GLP-1. The company's long-acting human growth hormone drug candidate, which is expected to ...

Growing Awareness and Increased Investments Lead to Growth of Biotechnology Applications in the Food & Beverage and Dietary Supplements Sector, Reveals Frost & Sullivan

... or guidelines on health claims in India is a growth restraining factor. According to a Frost ... & Middle East, "The market has good scope of growth considering the positive growth of the Indian food processing industry in terms ...

Sigma-Aldrich (Nasdaq:SIAL) Reports Q2 2009 Diluted EPS of $0.68; YTD Diluted EPS up 1.5% to $1.36. Full Year 2009 Guidance Reaffirmed, With 2009 Diluted EPS Expected to Exceed 2008's $2.65.

... of reported to adjusted (organic) sales growth are on page 7. Operating and pretax ... in the second quarter from global sales growth initiatives and profit enhancement activities ... reaffirmed its full year 2009 organic sales growth expectation in a low single digit range. This ...

Peregrine Pharmaceuticals Licenses Anti-VEGF Antibodies to Affitech

... preclinical anti-VEGF (Vascular Endothelial growth Factor) antibody program. Under the terms of the ... antibody program, targets the cancer-promoting growth factor VEGF. Data presented at IBC's 5th Annual ... as Avastin(R) (bevacizumab) in inhibiting tumor growth in a number of models of human cancers, including ...

Neogen Reports 16% Increase in Revenues

... ahead for us, and we will continue to execute the growth strategies necessary to seize the opportunities." ... addition, we were pleased to see our percentage growth in operating income exceed our percentage growth in revenue for the fourth quarter as we continue ...

Schering-Plough Reports Financial Results for 2009 Second Quarter

... tough challenges - delivering operational sales growth and reconciled earnings-per-share growth for the second quarter," said Fred Hassan, ... second quarter of 2008, reflecting operational growth of 4 percent and an unfavorable impact from ...

Big Pharma to Big Biopharma: Frost & Sullivan Examines the Latest M&A Trends and Opportunities

... & Sullivan: Frost & Sullivan, the growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, growth Consulting and growth Team Membership empower clients to create a ...

OpenQ Posts a 200% Revenue Growth in the First Half of 2009

... OpenQ announces solid revenue growth for the first half of 2009 and is now serving 7 ... announced today a continuing trend of profitable growth amidst global turmoil in the Life Sciences market. OpenQ posted a phenomenal 200% revenue growth in the first half of 2009 as compared to the same ...

Essilor : First Half 2009 Revenue

... - Strong growth in First-Half Revenue, up 9.4% - Operating ... polarized lens in the United States. - Firm growth in entry-level products, where Essilor holds ... in instruments. The strong 6% growth from changes in the scope of consolidation ...

STALLERGENES: Strong Sales Growth in 1st Half-Year: up 12% Full-Year Guidance Maintained

... included HY1 sales 2nd quarter growth remained high at 9% (organic* 8%), but slowed ... with the very strong start of the year. Sales growth over the first half-year remained strong at 12% ... operations to a subsidiary in Switzerland. growth was more moderate in Southern Europe (up 9%). In ...

China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results

... year ago. The increase resulted from significant growth in the sales of new products, most of which were ... the Company's Shining-branded retail outlets, and growth in the bulk additive business. The Company's ... assistants contributed to the rapid revenue growth from new products through its customer-oriented ...

Gerresheimer Holds its own in Difficult Environment

... Plastics) at Prior Year Level - growth in the Pharma Business - Sales Decline in ... This result was mainly attributable to sales growth for pharmaceutical packaging and systems, with ... in focusing the business," Herberg adds. growth for pharmaceutical products Regardless of ...

New Report Just Published: World Prostate Cancer Therapeutics Market Report

... Prostate Cancer Therapeutics Market II-6 growth Drivers II-6 Rise in Prostate Cancer Incidences & Access to Modern Therapeutics Foster growth II-6 Table 2: New Incidences of Prostate ... II-8 Supportive Cancer Drugs Contribute to growth II-8 Select FDA Approved Drugs for Palliative ...

ArborGen and Senesco Announce Wood Quality Results

... technology have shown significantly enhanced growth rates in 3-year-old field trials. Selected ... gravity, between the trees with the enhanced growth attributes and untreated control trees. This is good news as fast tree growth is often associated with lower wood quality. ...

PROLOR Biotech Awarded Two U.S. Patents for Its Longer-Acting Human Growth Hormone and Longer-Acting Erythropoietin

... for the company's long-acting CTP-enhanced human growth hormone (hGH-CTP) and human erythropoietin ... two new patents covering CTP-enhanced human growth hormone and erythropoietin represent another ... with hGH-CTP, its longer-acting version of human growth hormone, later this year. The issue date for ...

Global Small Molecule Kinase Inhibitors Market to Reach $16.2 Billion by 2015, According to a New Report by Global Industry Analysts, Inc.

... metabolism, proliferation, and DNA damage. Strong growth in the future will be led by expansion of ... years are forecast to witness both the strong growth for multi-targeted kinase inhibitors, and the ... to regroup to recalibrate and spread through new growth paths. Global sales of Gleevec are ...

Global Prescription Drugs Market to Cross $897 Billion by 2015, According to New Report by Global Industry Analysts, Inc.

... deceleration in growth. Key factors slowing down growth in the global prescription drugs market include ... and pharmacogenomics, which are spearheading growth in the industry. San ... slowdown in 2009 and 2010, with declines or flat growth expected in mature markets such as the US, Japan, ...

UCF team's advanced nerve cell system could help cure diabetic neuropathy, related diseases

... impacts of different chemical components. Once growth in serum is accomplished, researchers will often ... so they decided to attempt myelination using the growth medium they have spent years tweaking. ... while serum contains components that promote cell growth it may also contain some that inhibit growth. ...

SyntheMed Receives Frost & Sullivan Health Innovation Award Nomination

... Frost and Sullivan Frost & Sullivan, the growth Consulting Company, partners with clients to accelerate their growth. The company's growth Partnership Services, growth Consulting and Career Best Practices empower ...

Government Mandates Create Guaranteed Market for Bio-Fuel, Says Frost & Sullivan

... is a smaller market, it is witnessing rapid growth in terms of both new bio-diesel capacities coming ... bio-diesel, there are several strong drivers of growth for both increased supply as well as demand. ... subsidies or tax exemption, will in turn spur growth for the development of bio-diesel." About ...

PTC Therapeutics Receives $2.6 Million in Government Grants

... of new blood vessels, and supports tumor growth in patients with NF2. PTC299 is a novel, orally ... production of the protein vascular endothelial growth factor (VEGF) in tumors, while sparing ... production of the protein vascular endothelial growth factor, or VEGF, in tumors. PTC discovered ...

Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program

... its existing development pipeline and future growth opportunities to a much larger audience of ... investment community are properly informed of our growth strategy and competitive advantages. We are ... healthcare plan and the long-term, secular growth opportunity in China," said Matthew Hayden, ...

OpenQ is Awarded Prestigious Life Sciences Industry Award

... OpenQ wins the 2009 Global Pharmaceutical CRM growth Strategy Leadership of the Year presented by ... the prestigious 2009 Global Pharmaceutical CRM growth Strategy Leadership of the Year award, presented ... the company that has demonstrated an exceptional growth strategy within the industry. A ...

Modigene Shareholders Approve Company Name Change and Other Proposals at Annual Meeting

... such as follicle stimulating hormone, human growth hormone, interferon beta, erythropoietin, Factor ... trial with our longer-acting version of human growth hormone, signalling our transformation into a ... developing long-acting versions of human growth hormone, interferon beta and erythropoietin, ...
Other Contents
(Date:8/28/2014)...  Privacy Advocate and Senior Staff Attorney at the ... the lineup of biometric and mobile commerce experts set ... Summit in Tampa, Florida on ... include Steven Rahman, Director, Technology and Strategy at Samsung, and ... theme of this year,s event is Mobility at the ...
(Date:8/28/2014)... WASHINGTON, Aug. 28, 2014A new method for measuring and ... help doctors and researchers better understand how drug abuse ... surgery and tissue engineering, and lead to better treatment ... by a team of researchers from Stony Brook University ... of Health, was published today in The Optical Society,s ...
(Date:8/28/2014)... mould in homes could pose a significant health risk to ... the Journal of Allergy and Clinical Immunology . , ... different countries, the research has found that the presence of ... asthma sufferers, as well as increasing the likelihood of developing ... team at the University of Exeter Medical School and is ...
Breaking Biology News(10 mins):Biometrics UnPlugged Welcomes the Electronic Frontier Foundation's Jennifer Lynch to the Mobility at the Crossroads of Commerce and Privacy Summit 2This is your brain's blood vessels on drugs 2This is your brain's blood vessels on drugs 3Indoor mold poses health risk to asthma sufferers 2
(Date:8/29/2014)... As reported by WKMS.com in the article ... municipal court drug has come up with a new strategy ... as the presiding judge in a Southeastern Ohio municipal court ... a medicated treatment option that can literally prevent them from ... Vivitrol, which blocks receptors in the brain that would normally ...
(Date:8/29/2014)... by the Frederick News Post in the article Run For ... the Frederick County Drug Treatment Court has found a new way ... graduate, Korey Shorb, put together a race called Run For Recovery ... donate the proceeds of the event to the program he graduated ... graduated in 2008, admitted that he would probably be in jail ...
(Date:8/29/2014)... Healthpointe is proud to welcome to ... will be practicing out of Healthpointe’s newest office directly ... Healthpointe’s orthopedic team, Dr. Rodas is board-certified ... in occupational medicine. , Among Dr. Rodas’ many ... of Raytheon, the world-class defense and aerospace company. Additionally, ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Healthpointe ... Chapman University Physical Therapy students via Clinical Rotations. ... University will be shadowing Healthpointe providers and specialists ... them to develop clinical experience and learn professional ... students will gain insight into several patient care ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Pursuing its ... is set to unveil a stunning new design that ... company figures, the highly notable surrogacy platform has witnessed ... With over 13,000 visitors a month, the FindSurrogateMother.com community ... working toward one common goal — the precious gift ...
Breaking Medicine News(10 mins):Health News:Ohio Judge Pushes for Addiction Recovery Tool 2Health News:Ohio Judge Pushes for Addiction Recovery Tool 3Health News:Drug Court Grad Brings More Life to Drug Court Program 2Health News:Drug Court Grad Brings More Life to Drug Court Program 3Health News:Dr. Anthony G. Rodas Joins Healthpointe Team at LAX Office 2Health News:Healthpointe is Now Offering Clinical Rotations for Chapman University Physical Therapy Students 2Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 2Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 3
Other TagsOther Tags